Back

Disproportionate MR and 5-year mortality following acute heart failure hospitalisation

28 August 2023 (14:15 - 14:50)
Organised by: Logo
Congress Presentation Part of: Effects and treatment of comorbidities in acute heart failure Imaging ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Max Berrill

St Bartholomew's Hospital, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Impact of systemic lupus erythematosus on outcomes in patients hospitalized with acute decompensated heart failure with reduced and preserved ejection fraction: a national inpatient sample study (2016
Doctor S. Nomigolzar (Greenville, US)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronosation and left ventricular ejection fraction improvement with single ventricular conduction pacing system lead
Mr F. Ayala Valani (Sherbrooke, CA)
Abstract Slides Video
Presentation thumbnail
Deep night: critical periods for the onset of acute myocardial infarction in obstructive sleep apnea patients
Doctor Y. Wang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
The clinical prognosis of elderly patients with decompensated congestive heart failure greatly improved for 7 years after introduction of our unique clinical pathway
Doctor T. Endo (Kanonji, JP)
Abstract Slides Video
Presentation thumbnail
Outcome of transcatheter mitral valve repair in heart failure patients with reduced ejection fraction and severe left ventricular dilatation
Doctor M. Sone (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Effects and treatment of comorbidities in acute heart failure

The Event

Event poster

ESC Congress 2023

28 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Session
The different faces of mitral regurgitation
thumbnail
Congress Presentation
Prognostic significance of mitral regurgitation in acute heart failure stratified by ejection fraction
thumbnail
Congress Presentation
Prognostic impact of normalizing 3D mitral RegVol to LAVmax in HFrEF patients with ventricular secondary MR

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources